暂时的SP140抑制解锁了来自人类多能干细胞的造血干细胞命运
Xingjie Liu1, Zhiwei Zhang1, Xinyu Cui1
1Tongji University, Shanghai, China.
Blood
|December 15, 2025
概括
暂时抑制SP140解锁表观遗传障碍,使可移植的人类造血干细胞 (HSC) 从多能干细胞 (hPSC) 有效生成用于再生医学.
科学领域:
- 干细胞生物学 干细胞生物学
- 血液形成 血液形成 血液形成
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 从人类多能干细胞 (hPSC) 提取可移植的造血干细胞 (HSC) 的有效衍生受到表观遗传沉默的阻碍.
- 识别调节高血小板出现的因素对于促进再生性血液形成至关重要.
研究的目的:
- 为了确定抑制hPSCs的血液形成的表观遗传调节剂.
- 制定一项战略,为移植提供高效的HSC生成.
主要方法:
- 使用BCL11A-eGFP报告员进行CRISPR/Cas9查.
- 在hPSC衍生的培养和小鼠模型中抑制SP140.
- 转录基因分析和CUT&Tag分析.
- 通过对免疫缺陷小鼠进行连续移植来评估HSC功能.
主要成果:
- SP140被确定为一种抑制血液形成的表观遗传阅读器.
- 暂时的SP140抑制促进了强大的多系血型形成,并加速了HSC的产生.
- SP140阻塞通过托波酶1依赖色素重塑激活了关键的造血程序.
- 抑制SP140使得体外快速生成适合移植的真实人类HSCs.
结论:
- 暂时的SP140抑制克服了hPSC中的表观遗传障碍.
- 这一策略促进了临床相关的HSCs用于细胞疗法和再生血液形成的生成.
- SP140作为HSC规范的保存表观遗传守门员.
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K


